Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Nicotinamide Adenine Dinucleotide

VitaminNAD

A heavily-marketed 'longevity' supplement. The honest truth: NAD+ itself is poorly absorbed orally (large, polar molecule, degraded in the gut), and there are no published human RCTs showing oral NAD+ raises systemic NAD+ levels. Most marketing extrapolates from research on its precursors (NR, NMN) — and even those precursor trials show NAD+ levels rise without consistent clinical benefit in healthy adults.

Quick decision guide

May help most

Not currently a recommendable supplement based on the evidence. People interested in NAD+ biology should consider precursors (NR, NMN) under a clinician's care — they at least raise blood NAD+, though clinical benefit remains unproven.

Common dosing range

There is no evidence-based oral NAD+ dose because oral NAD+ doesn't reliably raise systemic NAD+. Marketed doses are typically 100–500 mg/day; the evidence supports neither efficacy nor an optimal dose.

When to expect effects

Not established. Precursor (NR/NMN) trials show blood NAD+ rises within days; clinical-endpoint changes are usually not seen at all.

Watch out for

Don't conflate oral NAD+ with IV NAD+ or with the precursor literature. The longevity / anti-aging claims circulating on social media have no support from published human RCTs.

Evidence snapshot

Oral NAD+ raises systemic NAD+Low
Precursors (NR, NMN) raise blood NAD+Strong
Clinical longevity / healthspan benefitLow
Muscle / metabolic outcomes from NMNLow

What is it

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells, essential for energy metabolism and hundreds of enzymatic reactions. Its reduced form, NADH, is sold as a supplement, as are precursors including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You're scientifically curious about NAD+ biology and accept that current evidence does not support the supplement form for clinical benefit
You're considering nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — precursors that at least raise blood NAD+ — under medical guidance

Probably skip if…

You're hoping to slow aging, extend lifespan, or reverse age-related decline — no human RCT shows oral NAD+ does any of these
You're paying a premium for 'NAD+' capsules — there is no evidence they raise systemic NAD+
You're attracted by celebrity / influencer testimonials — these aren't evidence
You have cancer or are at high cancer risk — NAD+ metabolism interacts with tumor biology; do not self-supplement without an oncologist's input
You're substituting NAD+ supplements for established interventions (exercise, sleep, diet, treating actual conditions)

Evidence at a glance

Metabolic / insulin sensitivity (precursor NMN data)

Limited Evidence
Effect
Improved muscle insulin sensitivity in one RCT in prediabetic postmenopausal women; not replicated, and not a direct-NAD+ trial
Best fit
Prediabetic postmenopausal women under clinician guidance — and only as NMN, not as oral NAD+
Time
10 weeks in Yoshino 2021

Raising systemic NAD+ (the supplement's stated purpose)

Mixed Evidence
Effect
No human RCT data showing oral NAD+ raises systemic NAD+. Precursors (NR 300–1000 mg/day, NMN 250–500 mg/day) reliably raise blood NAD+ by ≈40–100%.
Best fit
Nobody — based on current evidence, take a precursor (NR or NMN) instead if you want to raise NAD+, under clinician guidance
Time
Not established for direct NAD+; precursors raise blood NAD+ within days

Longevity, healthspan, anti-aging

Mixed Evidence
Effect
No demonstrated effect on human lifespan, healthspan, or robust aging biomarkers in published RCTs
Best fit
Not currently supported by evidence for any healthy adult
Time
Not established

Cardiovascular function (precursor NR data)

Mixed Evidence
Effect
Trend (not statistically robust) toward lower BP and arterial stiffness in 24-person crossover with NR — not replicated; not powered for clinical CV outcomes
Best fit
Not currently supported as a CV intervention for any specific population
Time
6 weeks in the Martens trial

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Metabolic / insulin sensitivity (precursor NMN data)

Biomarker support
Limited Evidence

Yoshino et al. 2021 (Science) showed 250 mg/day NMN for 10 weeks improved muscle insulin sensitivity in 25 prediabetic postmenopausal women — a real signal but in a narrow population. Notably, muscle NAD+ content was NOT detected to rise despite the biomarker change, suggesting the mechanism is unclear. The 2025 NMN meta-analysis (12 RCTs, n=513) found inconsistent effects on glucose and lipid markers overall. This is precursor (NMN) data, not direct NAD+ data.

Effect size
Improved muscle insulin sensitivity in one RCT in prediabetic postmenopausal women; not replicated, and not a direct-NAD+ trial
Time to effect
10 weeks in Yoshino 2021
Best fit
Prediabetic postmenopausal women under clinician guidance — and only as NMN, not as oral NAD+
Less likely
General healthy adults expecting metabolic benefit from oral NAD+

Bottom line: Promising single-trial signal in one narrow population — for the precursor NMN, not oral NAD+. Don't generalize.

SourceYoshino et al., 2021 — ScienceZhang et al., 2025 — Critical Reviews in Food Science and Nutrition

Raising systemic NAD+ (the supplement's stated purpose)

Biomarker support
Mixed Evidence

There are no published human RCTs demonstrating that oral NAD+ supplementation raises blood NAD+ levels. NAD+ is a large, charged molecule that is degraded by digestive enzymes and faces extensive first-pass metabolism — pharmacokinetic principles predict negligible bioavailability for the intact molecule. In contrast, the precursors nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) do reliably raise whole-blood NAD+ in multiple RCTs (Martens 2018, Conze 2019, Zhang 2025 meta-analysis). If you want to raise NAD+, the evidence supports precursors, not direct NAD+.

Effect size
No human RCT data showing oral NAD+ raises systemic NAD+. Precursors (NR 300–1000 mg/day, NMN 250–500 mg/day) reliably raise blood NAD+ by ≈40–100%.
Time to effect
Not established for direct NAD+; precursors raise blood NAD+ within days
Best fit
Nobody — based on current evidence, take a precursor (NR or NMN) instead if you want to raise NAD+, under clinician guidance
Less likely
Adults expecting that the NAD+ capsule they bought actually delivers NAD+ to their cells

Bottom line: Oral NAD+ does not reliably do what the label says. Precursors (NR, NMN) have better-substantiated biomarker effects but unproven clinical benefit.

Evidence is mixed

Marketing and influencer claims dramatically outrun the published evidence. The strongest 'NAD+' RCT data (Martens 2018, Yoshino 2021, Conze 2019, Zhang 2025 meta) all use precursors (NR or NMN), not direct NAD+. Researchers in the field (Freeberg 2024 Science Advances; Zhang 2025) have explicitly warned about hype outpacing data.

SourceFreeberg et al., 2024 — Science Advances· conflictingZhang et al., 2025 — Critical Reviews in Food Science and Nutrition· conflicting
SourceMartens et al., 2018 — Nature CommunicationsConze et al., 2019 — Scientific ReportsFreeberg et al., 2024 — Science Advances

Longevity, healthspan, anti-aging

Mechanism only
Mixed Evidence

No long-term randomized controlled trials have shown oral NAD+ — or its precursors — extends human lifespan or healthspan. The longevity case rests on animal data (worms, flies, mice) where NAD+ precursors improve some markers of aging, and on the observation that NAD+ levels decline with age. Translation to humans has been disappointing: a 2025 meta-analysis of 12 NMN RCTs (Zhang et al.) found no consistent benefit on muscle, metabolic, or physical-function endpoints. The field's leading reviewers explicitly warn that influencer hype is outrunning the data.

Effect size
No demonstrated effect on human lifespan, healthspan, or robust aging biomarkers in published RCTs
Time to effect
Not established
Best fit
Not currently supported by evidence for any healthy adult
Less likely
Everyone — the longevity claim is currently unsupported by human RCT data

Bottom line: The longevity case is hype, not evidence. Don't buy 'anti-aging' or 'cellular rejuvenation' marketing claims.

Evidence is mixed

Strong animal data, plausible mechanism, weak-to-null human RCT translation. The Zhang 2025 meta-analysis of NMN explicitly cautions against benefit exaggeration. There are no long-term healthspan or mortality RCTs of NAD+ or its precursors in humans.

SourceZhang et al., 2025 — Critical Reviews in Food Science and Nutrition· conflictingFreeberg et al., 2024 — Science Advances· conflicting
SourceZhang et al., 2025 — Critical Reviews in Food Science and NutritionFreeberg et al., 2024 — Science Advances

Cardiovascular function (precursor NR data)

Biomarker support
Mixed Evidence

Martens 2018 (Nature Communications), a small crossover RCT (n=24) of 1000 mg/day nicotinamide riboside, showed a trend toward reduced systolic blood pressure (~10 mmHg in subgroup) and arterial stiffness. The trial was not powered for cardiovascular endpoints. No subsequent large RCT has confirmed a clinical cardiovascular benefit for either NR or NMN, and this is precursor data not direct-NAD+ data.

Effect size
Trend (not statistically robust) toward lower BP and arterial stiffness in 24-person crossover with NR — not replicated; not powered for clinical CV outcomes
Time to effect
6 weeks in the Martens trial
Best fit
Not currently supported as a CV intervention for any specific population
Less likely
Adults seeking proven cardiovascular benefit

Bottom line: Interesting signal in a small precursor trial; not enough to recommend the supplement (and oral NAD+ isn't what was tested anyway).

SourceMartens et al., 2018 — Nature Communications

How it works

NAD+ functions as a hydrogen and electron carrier in cellular energy production, particularly in glycolysis and oxidative phosphorylation. It cycles between NAD+ and NADH forms during these reactions, ultimately enabling ATP synthesis from food. NAD+ is also a substrate for several important enzyme families including sirtuins (deacetylases involved in stress responses and longevity pathways), PARPs (involved in DNA repair), and CD38 (involved in immune signaling). These NAD+-consuming enzymes mean that maintaining adequate NAD+ levels is essential for proper cellular function, and NAD+ declines with age have been hypothesized to contribute to age-related dysfunction. Research on NAD+ supplementation typically uses precursors like NR or NMN rather than NAD+ itself, since direct NAD+ has poor oral bioavailability. NADH (the reduced form) is also used as a supplement. Most clinical evidence focuses on precursors raising NAD+ levels and effects on energy, mitochondrial function, and various age-related parameters, with research still in early stages.

How to take it

1. Typical dose
• Marketed oral NAD+ doses are 100–500 mg/day, but there is NO evidence-based dose because oral NAD+ doesn't reliably raise systemic NAD+ • If you want to raise NAD+, the evidence supports precursors instead: – Nicotinamide riboside (NR): 300–1000 mg/day (safety up to 2000 mg/day in trials) – Nicotinamide mononucleotide (NMN): 250–500 mg/day (Yoshino 2021 used 250 mg)
2. Higher studied dose
Oral NAD+: no high-dose human RCT data. NR has been tested up to 2000 mg/day safely. NMN has been tested up to 900 mg/day. Higher doses don't appear to translate into greater clinical benefit.
3. Timing
Not established for oral NAD+. Most precursor trials use morning dosing with or without food; either appears acceptable.
4. With food
With or without food — neither has shown a clear advantage in precursor trials.
5. Split dosing
Not established for oral NAD+. Single morning dose is the most common precursor protocol.
6. How long to try
If you choose to try a precursor: 8–12 weeks is the typical trial duration. Reassess based on any subjective change and the cost — most trials show biomarker changes without consistent clinical benefit, so 'how you feel' may not change.

What to track

Subjective energy and exercise capacity (most trials show no objective change)
Blood pressure and resting heart rate (small trends in some precursor trials)
Cost — these supplements are expensive and benefit is unproven
Skin flushing (with nicotinamide / niacinamide; less with NR/NMN)

Bottom line: If you're going to spend money in this space, prefer a precursor (NR or NMN) with at least biomarker-level evidence over direct oral NAD+. Better yet: spend the money on exercise equipment, sleep hygiene, or a vegetable-heavy diet — all of which have stronger evidence for healthy aging.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Direct oral NAD+ (capsules, sublingual)

Unproven

Sold widely as longevity supplements. No published human RCT shows oral NAD+ raises systemic NAD+ levels. The molecule is large, polar, and likely degraded in the gut and by first-pass liver metabolism. Sublingual claims are not backed by pharmacokinetic data.

Very low predicted oral bioavailability; no human PK data supports the marketed claim.

Nicotinamide Riboside (NR)

Best-studied precursor

An NAD+ precursor. Most extensively studied form: multiple RCTs show 300–1000 mg/day reliably raises whole-blood NAD+ in 1–2 weeks. Clinical-endpoint benefit (cardiovascular, metabolic, cognitive) remains unproven in healthy adults.

Well absorbed; raises blood NAD+ dose-dependently.

Nicotinamide Mononucleotide (NMN)

Popular precursor

Another NAD+ precursor. Raises blood NAD+ at 250–900 mg/day. The Yoshino 2021 Science trial showed muscle insulin-sensitivity benefit in prediabetic postmenopausal women; broader benefits in healthy adults are not consistently demonstrated (Zhang 2025 meta-analysis).

Reliably raises blood NAD+; clinical benefit limited to narrow populations.

Niacin (nicotinic acid) / Niacinamide (nicotinamide)

Classic precursors

The original NAD+ precursors — RDA-level vitamin B3. Cheap and well established for niacin deficiency (pellagra). High-dose niacin causes flushing; niacinamide doesn't. Will raise NAD+ but isn't sold as a 'longevity' product, so the marketing premium isn't there.

Excellent oral absorption; precursor to NAD+ via the salvage pathway.

IV NAD+ infusion

Bypasses gut

Intravenous NAD+, marketed at wellness clinics for energy, addiction recovery, and 'cellular health'. Bypasses gut degradation and first-pass metabolism. Limited published human RCT evidence; expensive; not the same product as oral NAD+ capsules — don't conflate the two.

100% systemic exposure by infusion; clinical benefit data still limited.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

nausea (rare)fatigue (uncommon)flushing (more common with nicotinamide / niacinamide; less with NR/NMN/NAD+)headache (uncommon)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

No safety data in pregnancy or lactation. Avoid. Pregnant women have well-defined niacin RDAs (18 mg/day) that should be met from food and prenatal vitamins, not from high-dose NAD+ precursor supplements.

SourceFreeberg et al., 2024 — Science Advances

Bottom line: Short-term safety in healthy adults appears OK for NR and NMN at studied doses. Long-term safety is unknown; cancer-biology concerns are real and warrant clinician input.

Interactions

chemotherapy regimens involving NAD+ pathway (PARP inhibitors)Major

NAD+ and its precursors directly engage the same pathways targeted by some chemotherapies. Theoretical risk of antagonizing chemo effect. Do not combine without oncologist guidance.

SourceFreeberg et al., 2024 — Science Advances
metforminMinor

Both modulate cellular energy/NAD+ pathways. No documented serious interaction; theoretical additive effects on glucose handling. Monitor blood glucose if combining.

SourceYoshino et al., 2021 — Science
niacin (nicotinic acid)Minor

Same metabolic pathway. Combining high-dose niacin with NAD+ precursors is redundant; no benefit and may increase flushing.

Food sources

Beef liver, cooked

Amount
3 oz (14.9 mg niacin)
%DV
93%

Chicken breast, roasted

Amount
3 oz (10.3 mg niacin)
%DV
64%

Tuna, canned in water

Amount
3 oz (8.6 mg niacin)
%DV
54%

Turkey breast, roasted

Amount
3 oz (6.0 mg niacin)
%DV
38%

Salmon, sockeye, cooked

Amount
3 oz (8.6 mg niacin)
%DV
54%

Beef, ground 90% lean, cooked

Amount
3 oz (5.6 mg niacin)
%DV
35%

Peanuts, dry roasted

Amount
1 oz (4.2 mg niacin)
%DV
26%

Pork loin, cooked

Amount
3 oz (6.3 mg niacin)
%DV
39%

Sunflower seeds, dry roasted

Amount
1 oz (2.0 mg niacin)
%DV
13%

Whole wheat bread

Amount
1 slice (1.4 mg niacin)
%DV
9%

Brown rice, cooked

Amount
½ cup (1.5 mg niacin)
%DV
9%

Avocado

Amount
1 medium (3.5 mg niacin)
%DV
22%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Single-ingredient product if you must try it — combination 'longevity' formulas hide what's actually doing what
Third-party tested for purity and label accuracy — NAD+ and precursors are expensive and adulteration risk is real
If choosing a precursor instead, look for NIAGEN (branded NR) or Uthever / Mirai Lab branded NMN — these have third-party data
Stable, cold-shipped products if buying NMN (claims of instability)
Transparent cost-per-day calculation — these supplements are very expensive for unproven benefit

Be skeptical of…

'Reverses aging' or 'cellular rejuvenation' — no human RCT supports these claims
'Boosts NAD+ by X%' for oral NAD+ products — no published evidence oral NAD+ raises systemic NAD+ at all
Celebrity endorsements as proof — testimonials are not data
'Same as IV NAD+' — completely different pharmacokinetics; IV bypasses gut and first-pass metabolism
Bundling with unproven 'longevity' supplements (resveratrol, fisetin, spermidine) at premium prices
Mega-dose products (>1000 mg/day) — no evidence higher doses help; safety beyond studied ranges is unknown

Frequently asked questions

What is the difference between NAD+ and NADH?⌄

NAD+ is the oxidized form; NADH is the reduced form. They cycle back and forth during cellular energy production. NAD+ is the form needed for sirtuin and PARP enzymes; NADH is used in mitochondrial energy generation.

Should I take NAD+ directly or use a precursor?⌄

Direct NAD+ has poor oral bioavailability. Precursors like NR and NMN raise NAD+ levels more effectively. Most clinical research uses precursors.

Does NAD+ slow aging?⌄

Strong preclinical evidence suggests NAD+ supports cellular functions involved in aging. Human clinical trials have shown precursors can raise NAD+ but clear effects on aging or longevity have not yet been demonstrated.

Are NMN and NR the same?⌄

Both are NAD+ precursors. NMN is one step closer to NAD+ than NR in the biosynthesis pathway. Both effectively raise NAD+ levels in human studies.

How much should I take?⌄

Common doses are 250-500 mg of NR or 250-1000 mg of NMN daily. For NADH, 5-20 mg per day is typical. There is no established optimal dose; research is ongoing.

References by claim

Raising systemic NAD+ (the supplement's stated purpose)

Martens et al., 2018 — Nature Communications (2018) link

Zhang et al., 2025 — Critical Reviews in Food Science and Nutrition (2025) link

Freeberg et al., 2024 — Science Advances (2024) link

Conze et al., 2019 — Scientific Reports (2019) link

Metabolic / insulin sensitivity (precursor NMN data)

Yoshino et al., 2021 — Science (2021) link

Other references

Nicotinamide adenine dinucleotide on Wikidata — Wikidata link

NAD+ (PubChem CID 5893) — PubChem link

Track Nicotinamide Adenine Dinucleotide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.